Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (271)	8/20/2007 5:37:16 PM
From: rkrw	Respond to of 684

Tough call. I probably wouldn't have guessed prcs last time!

To: Steve Lokness who wrote (271)	8/20/2007 5:42:37 PM
From: BulbaMan	Read Replies (2) \| Respond to of 684

I like COLY as a bet on TLR technology. However, I should note, at the last beer bash one biofreak described COLY's programs as "crap." Maybe so, but I think COLY has the kind of crap that will continue to get substantial support through big pharma partnerships.